Preferred Label : Hypomagnesemia 3, renal;
Symbol : HOMG3;
CISMeF acronym : HOMG3;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Hypomagnesemia, primary, due to defect in renal tubular transport of magnesium; Hypomagnesemia, isolated renal; Hypomagnesemia, familial, with hypercalciuria and nephrocalcinosis;
Included titles and symbols : Hypercalciuria, childhood, self-limiting;
Description : Familial hypomagnesemia with hypercalciuria and nephrocalcinosis is a progressive
renal disorder characterized by excessive urinary Ca(2 ) and Mg(2 ) excretion. There
is progressive loss of kidney function, and in about 50% of cases, the need for renal
replacement therapy arises as early as the second decade of life (summary by Muller
et al., 2006). A similar disorder with renal magnesium wasting, renal failure, and
nephrocalcinosis (HOMG5; 248190) is caused by mutations in another tight-junction
gene, CLDN19 (610036), and is distinguished by the association of severe ocular involvement.
For a discussion of phenotypic and genetic heterogeneity of familial hypomagnesemia,
see HOMG1 (602014).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the claudin 16 gene (CLDN16, 603959.0001);
Laboratory abnormalities : Hypomagnesemia; Normal serum calcium; Elevated parathyroid hormone; Hyperuricemia; Hypermagnesiuria; Hypercalciuria; Hypocitraturia; Hematuria; Abacterial leukocyturia;
Prefixed ID : #248250;
Origin ID : 248250;
UMLS CUI : C0268448;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
Not associated HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)